Chemo plus MRI-guided radiation before esophageal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests combining chemotherapy (FLOT) with a special type of MRI-guided radiation before surgery for esophageal adenocarcinoma. It aims to improve treatment results for patients with a specific type and stage of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of esophageal cancer called adenocarcinoma (a common type).
- Your tumor is in part of the esophagus that is still surgically removable, and you are healthy enough for surgery after treatment.
- You are eligible to receive a chemotherapy combination known as FLOT.
- Your tumor is 10 cm or smaller in length.
- You have not had radiation to the chest area or surgery on your esophagus before.
- You are 18 or older and are able to have an MRI scan (no metal implants that prevent MRI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs given together with radiation therapy, followed by additional chemotherapy, for newly diagnosed adenocarcinoma (a type of cancer) in the esophagus or where the esophagus meets the stomach. The goal is to shrink the tumor and improve survival.
This trial tests adding an immunotherapy drug (tislelizumab) to standard chemotherapy (FLOT) before surgery for people with stomach or esophagus cancer that can be removed but hasn't spread. The goal is to see if this combination is safe and works better than chemotherapy alone.
This trial tests whether giving a higher dose of radiation to the main tumor, guided by MRI scans, can improve treatment for a type of esophageal cancer called squamous cell carcinoma. You would first receive standard chemoradiation followed by surgery.
This trial is testing a combination of chemotherapy and radiation (called total neoadjuvant therapy) before surgery for a type of esophageal cancer that has spread to lymph nodes. The goal is to see if this approach improves outcomes.
This trial tests a personalized approach using MRI guidance for chemoradiotherapy combined with immunotherapy for limited advanced esophageal squamous cell cancer that cannot be surgically removed or has spread only to nearby lymph nodes. It aims to improve treatment effectiveness while reducing side effects.
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
Hear when a new Esophageal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.